CGON · CG Oncology, Inc.
$79.01
+0.59 (+0.75%)
At close · Aug 27
Market Cap
$6.94B
Shares
88.64M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$79.01
Open$78.01
Day$77.63–79.40
52W close$26.48–80.68
Avg vol 30d788K
Short int11.2M · 12.7% float · 14.9d
Short vol90%
DataJan 2024–Aug 2026
Filing10-Q · Aug 6
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
High
Market backdrop
VIX 14.5 · calm
Equity put/call 0.39
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+32%
above
Price vs 50-day avg
+9%
above
RSI (14)
58
neutral
MACD trend
Positive
52-week position
97%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+8%
trailing
6-month return
+28%
trailing
YTD return
+90%
this year
Relative strength
+13%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $73 › 200d $60 — 50d above 200d
Institutional flow
Distributing
-2% holders QoQ · +36 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
12.69% of float · ▼ -5.0% MoM · 14.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
234 holders — near 2-yr high, broad support
Squeeze score
76
high risk · 0–100
Fundamentals
Revenue growth
+255%
Y/Y
EPS growth
−48%
Y/Y
Free cash flow
$-132.5M
Balance sheet
$29.5M
net cash
Quant / Vol
risk profile
Volatility
57%
annualized · 1-yr
Max drawdown
−27%
past year
ATR
3.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+32%
Bullish
Price vs 50-day avg
+9%
Bullish
RSI (14)
58
Neutral
MACD trend
Positive
Bullish
52-week position
97%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $73 › 200d $60 — 50d above 200d
Institutional flow
Distributing
-2% holders QoQ · +36 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
12.69% of float · ▼ -5.0% MoM · 14.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
234 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $26
Now $79 · 97%
Range high $81
vs 200-day avg +32%
vs 50-day avg +9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CGON
this stock
CG Oncology, Inc.
|
$6.94B | +90.3% | +254.7% | — | 12.7% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.72B | +20.8% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.89B | +4.6% | +20.8% | 20.2 | 2.3% |
|
ARGX
Argenx SE
|
$65.12B | +25.9% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.92B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CGON | +1.8% | +8.2% | +27.7% | +11.0% | +90.3% |
| SPY | +1.1% | +4.0% | +14.7% | +3.2% | +13.1% |
| vs SPY | +0.7% | +4.2% | +13.0% | +7.8% | +77.2% |
Key facts
CIK
1991792
CUSIP
156944100
13F (30d)
212 filings
210 filers
Visit website
Investor relations